COR news

Cencora reported revised revenue figures showing a 5.1% year-over-year increase across its Pharmaceutical Distribution and Specialty Services segments for fiscal year-ended September 2026.

Cencora reported a record $337.4B in fiscal 2026 revenue driven by its MSO platform and new healthcare segments. The firm raised its quarterly dividend and expects significant FY27 earnings growth.

Coronado Global Resources Inc. announced the appointment of Sandeep Deoji as CFO of Curragh Queensland Mining Pty Ltd, effective Nov. 1, 2026. The move highlights the company's continued executive leadership restructuring.

Cencora agreed to acquire all equity interests in American Oncology Network that it does not already own in a deal valued at $2.4 billion, strengthening its community oncology footprint.

Cencora elected Robert E. Sanchez to its board. His logistics background supports the company's pharmaceutical strategy.

Cencora, Inc. filed an amendment to its $2.5 billion revolving credit agreement dated July 31, 2026. This refinancing significantly improves its debt profile by lowering interest rates to LIBOR-based rates and reducing the commitment fee.

Cencora reported a 5.1% increase in Q3 2026 revenue to $84.8 billion and raised its adjusted diluted EPS guidance range to $17.75 to $17.95. Net income attributable to the company increased to $764 million in the third quarter.

Silvana Battaglia is retiring after 7 years as CHRO, with Samantha Hammock from Verizon taking over effective July 13, 2026. Battaglia will serve as special advisor through year-end to ensure smooth transition of HR leadership at the pharmaceutical solutions company.